• P-ISSN2233-4203
  • E-ISSN2093-8950

Article Detail

Home > Article Detail
  • P-ISSN 2233-4203
  • E-ISSN 2093-8950

Quantification of Fargesin in Mouse Plasma Using Liquid Chromatography-High Resolution Mass Spectrometry: Application to Pharmacokinetics of Fargesin in Mice

Mass Spectrometry Letters, (P)2233-4203; (E)2093-8950
2022, v.13 no.1, pp.20-25
https://doi.org/10.5478/MSL.2022.13.1.20
Lee Min Seo (The Catholic University of Korea)
Lim Chang Ho (The Catholic University of Korea)
Bang Young Yoon (The Catholic University of Korea)
Lee Hye Suk (The Catholic University of Korea)

  • Downloaded
  • Viewed

Abstract

Fargesin, a tetrahydrofurofuranoid lignan isolated from Flos Magnoliae, shows anti-inflammatory, anti-oxidative, anti-allergic, and anti-hypertensive activities. To evaluate the pharmacokinetics of fargesin in mice, a sensitive, simple, and selective liquid chromatography-high resolution mass spectrometric method using electrospray ionization and parallel reaction monitoring mode was developed and validated for the quantification of fargesin in mouse plasma. Protein precipitation of 6 µL mouse plasma with methanol was used as sample clean-up procedure. The standard curve was linear over the range of 0.2–500 ng/mL in mouse plasma with the lower limit of quantification level at 0.2 ng/mL. The intra- and inter-day coefficient variations and accuracies for fargesin at four quality control concentrations including were 3.6-11.3% and 90.0-106.6%, respectively. Intra-venously injected fargesin disappeared rapidly from the plasma with high clearance values (53.2-55.5 mL/min/kg) at 1, 2, and 4 mg/kg doses. Absolute bioavailability of fargesin was 4.1-9.6% after oral administration of fargesin at doses of 1, 2, and 4 mg/kg to mice.

keywords
fargesin LC-HRMS mouse plasma pharmacokinetics


Submission Date
2022-03-07
Revised Date
2022-03-22
Accepted Date
2022-03-22
상단으로 이동

Mass Spectrometry Letters